Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction

American Heart Journal

Volumn 165, Issue 1, 2013, Pages

  Martin, Seth S ^a,b   Gosch, Kensey ^c   Kulkarni, Krishnaji R ^d   Spertus, John A ^c   Mathews, Robin ^a   Ho, P Michael ^e   Maddox, Thomas M ^e   Newby, L Kristin ^a   Alexander, Karen P ^a   Wang, Tracy Y ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d Atherotech Inc   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK ASSESSMENT; TREATMENT CONTRAINDICATION;

EID: 84870941622     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.10.005     Document Type: Article

References (31)

1. E.M. Antman, M. Hand, and P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction J Am Coll Cardiol 51 2008 210 247
2. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction J Am Coll Cardiol 44 2004 E1 E211
3. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction J Am Coll Cardiol 50 2007 e1 e157
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
5. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol 44 2004 720 732
6. J.H. O'Keefe Jr., L. Cordain, and W.H. Harris Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal J Am Coll Cardiol 43 2004 2142 2146
7. M.H. Davidson, K.C. Maki, and T.A. Pearson Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations Am J Cardiol 96 2005 556 563
8. R.D. Santos, D.D. Waters, and L. Tarasenko Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: the Lipid Treatment Assessment Project (L-TAP) 2 Am Heart J 158 2009 860 866
9. C. Melloni, B.R. Shah, and F.S. Ou Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry Am Heart J 160 2010 1121 1129
10. S.V. Arnold, P.S. Chan, and P.G. Jones Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry Circ Cardiovasc Qual Outcomes 4 2011 467 476
11. K.R. Kulkarni Cholesterol profile measurement by vertical auto profile method Clin Lab Med 26 2006 787 802
12. J. Ware Jr., M. Kosinski, and S.D. Keller A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220 233
13. J. Vaglio Jr., M. Conard, and W.S. Poston Testing the performance of the ENRICHD Social Support Instrument in cardiac patients Health Qual Life Outcomes 2 2004 24
14. R.B. Deber, N. Kraetschmer, and J. Irvine What role do patients wish to play in treatment decision making? Arch Intern Med 156 1996 1414 1420
15. G. Zou A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706
16. G.A. Nichols, and C.E. Koro Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients Clin Ther 29 2007 1761 1770
17. C. Baigent, L. Blackwell, and J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
18. V.G. Athyros, K. Tziomalos, and T.D. Gossios Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis Lancet 376 2010 1916 1922
19. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
20. G.C. Fonarow, A. Gawlinski, and S. Moughrabi Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822
21. D.C. Chan, W.H. Shrank, and D. Cutler Patient, physician, and payment predictors of statin adherence Med Care 48 2010 196 202
22. C. Melloni, K.P. Alexander, and F.S. Ou Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome Am J Cardiol 104 2009 175 181
23. W.H. Shrank, N.K. Choudhry, and M.A. Fischer The epidemiology of prescriptions abandoned at the pharmacy Ann Intern Med 153 2010 633 640
24. W.H. Shrank, T. Hoang, and S.L. Ettner The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions Arch Intern Med 166 2006 332 337
25. X. Ye, C.R. Gross, and J. Schommer Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study Clin Ther 29 2007 2748 2757
26. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
27. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
28. T.F. Boyden, K.J. Reid, and D.M. Buchanan Is cardiac rehabilitation associated with improved medication persistence following acute myocardial infarction? J Am Coll Cardiol 57 2011 E485
29. T.A. Pearson, I. Laurora, and H. Chu The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
30. F. Malek, I.J. Dvorak, and H. Strieborna Reaching target lipid levels and the natural history of diabetes mellitus in patients surviving acute coronary syndrome: a retrospective cohort study from a tertiary care outpatient clinic Exp Clin Cardiol 13 2008 25 28
31. http://www.jointcommission.org/assets/1/6/AMI-Statin-factsheet-10-1-10- revised.pdf. Accessed on 4/28/12.